Structural modeling revealed bovine lactoferricin's superior antimicrobial activity over human lactoferricin is explained by its more amphipathic beta-sheet structure and denser cationic surface — a 3D structural basis for species differences.
Key findingBovine lactoferricin's superior antimicrobial activity versus human lactoferricin was explained by more complete amphipathic beta-sheet formation and
What the researchers found
Bovine lactoferricin's superior antimicrobial activity versus human lactoferricin was explained by more complete amphipathic beta-sheet formation and denser cationic surface charge distribution, identified through 3D structural modeling.
Why it matters
Advances understanding in antimicrobial-peptides, infection, peptide-design research.
How the study worked
in-vitro study. Details in abstract.
What this study cannot tell us
See abstract for study-specific limitations.
How to read the evidence
preliminary evidence from in-vitro study.
When this study was published
Published in 2004.
The bigger picture
Contributes to the growing body of evidence in peptide research.
Questions still open
- Further research needed to confirm and extend findings.
- Clinical translation potential to be evaluated.
Common questions
What was studied?
What was found?
Read the original research
Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
FEMS microbiology letters, 238(1), 221-6
Citation
Farnaud, Sebastien; Patel, Alpesh; Odell, Edward W; Evans, Robert W. (2004). Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.. FEMS microbiology letters, 238(1), 221-6.